Literature DB >> 1845939

Limitation of transcatheter arterial chemoembolization using iodized oil for small hepatocellular carcinoma. A study in resected cases.

C Kuroda1, M Sakurai, M Monden, T Marukawa, T Hosoki, K Tokunaga, K Wakasa, J Okamura, T Kozuka.   

Abstract

The radiologic and histologic findings are presented of the resection of 14 small hepatocellular carcinomas (HCC), less than 2 cm in maximum diameter, after transcatheter arterial chemoembolization (TCE) using iodized oil. The effect of TCE on small HCC depended on the morphologic type of the tumors. When no extracapsular invasion of tumor cells occurred, TCE was extremely effective against encapsulated tumors. However, in nine of the 14 resected specimens, viable tumor cells remained in or around the tumor. The authors suggest that small HCC are not always curable with TCE alone and that a multi-disciplinary approach is necessary for patients with small HCC.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845939     DOI: 10.1002/1097-0142(19910101)67:1<81::aid-cncr2820670116>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

Review 1.  Ethanol injection for the treatment of hepatic tumours.

Authors:  C Bartolozzi; R Lencioni
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

2.  Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma.

Authors:  Bao-Ming Luo; Yan-Ling Wen; Hai-Yun Yang; Hui Zhi; Xiao-Yun Xiao; Bing Ou; Jing-Sheng Pan; Jian-Hong Ma
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

3.  A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements.

Authors:  Masatoshi Kudo; Kwang-Hyub Han; Sheng-Long Ye; Jian Zhou; Yi-Hsiang Huang; Shi-Ming Lin; Chung-Kwe Wang; Masafumi Ikeda; Stephen Lam Chan; Su Pin Choo; Shiro Miyayama; Ann Lii Cheng
Journal:  Liver Cancer       Date:  2020-05-13       Impact factor: 11.740

4.  Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization.

Authors:  Hamdy E A Ali; Ahmed A Emam; Ahmed A Zeeneldin; Reham Srour; Reda Tabashy; Eman D El-Desouky; Zakaria Y Abd Elmageed; Abdel-Hady A Abdel-Wahab
Journal:  Clin Biochem       Date:  2019-01-15       Impact factor: 3.281

5.  [Regression and therapy-resistance of primary liver tumors and liver metastases after regional chemotherapy and local tumor ablation].

Authors:  H-P Fischer
Journal:  Pathologe       Date:  2005-05       Impact factor: 1.011

6.  Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre-treatment findings.

Authors:  Roberto Miraglia; Giada Pietrosi; Luigi Maruzzelli; Ioannis Petridis; Settimo Caruso; Gianluca Marrone; Giuseppe Mamone; Giovanni Vizzini; Angelo Luca; Bruno Gridelli
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

7.  Combined therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation for small hepatocellular carcinoma.

Authors:  Wei-Zhu Yang; Na Jiang; Ning Huang; Jing-Yao Huang; Qu-Bin Zheng; Quan Shen
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

Review 8.  Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres.

Authors:  T Taguchi
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

9.  Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma.

Authors:  R Lencioni; C Vignali; D Caramella; R Cioni; S Mazzeo; C Bartolozzi
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Mar-Apr       Impact factor: 2.740

Review 10.  The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Authors:  Sung Wook Shin
Journal:  Korean J Radiol       Date:  2009-08-25       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.